Small changes can add up to big savings and Bristol-Myers Squibb knows that very well. Since 2015, the company has identified hundreds of opportunities to reduce emissions and energy and water consumption, equating to more than $11 million in cost savings.
Editor’s note: In recognition of Global Patient Week, held annually across Bristol-Myers Squibb to celebrate the company’s patient-focused culture, we’re sharing how our People and Business Resource Groups are driving change for diverse patient populations.
When Priscilla Ko, a manager in the Bristol-Myers Squibb Foundation and member of the PAN Asian Network People and Business Resource Group, watched her father-in-law lose his battle with an aggressive form of bile-duct cancer at the age of 61, the personal suddenly turned professional.
PRINCETON, N.J. and CAMBRIDGE, Mass., December 10, 2018 /3BL Media/ - Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today announced that ReviveMed and Strand Therapeutics are the winners of Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral.
For Darcy Doege, R.N., B.S.N., of the Levine Cancer Institute, finding cancer early in patients means hitting the road.
Darcy is the Program Coordinator for the Lung B.A.S.E.S. 4 Life Program for the Charlotte-based cancer center, which launched the first mobile lung screening unit in the U.S. in 2017. This innovative idea was built to increase the early detection of lung cancer for underserved populations across North and South Carolina, thanks to a grant from the Bristol-Myers Squibb Foundation
From building partnerships to help ensure patients have access to treatments to ensuring that its commitment to diversity and inclusion extends beyond the workplace, Bristol-Myers Squibb is steadfast in its commitment to being a good corporate citizen. The 2018 Global Citizenship Reports shares stories of the work the company is carrying out as part of its commitment to its people and the communities in which they live.
The Bristol-Myers Squibb Foundation is supporting emergency relief effort in the southeastern United States following Hurricane Florence, which made landfall in North Carolina on September 14. The storm is slowly moving across the Carolinas, causing widespread flooding, destroying homes and forcing thousands of residents to flee.